Countries World

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab

Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...

 January 28, 2022 | News

Eppendorf expands its portfolio to address customers’ separation needs

The introduction of the portfolio under the Eppendorf umbrella began with the launch of the CP22N and CP30NX high-speed, floor-standing centrifuges in 2021...

 January 26, 2022 | News

AHF Praises Merck for Generics – Urges Same from Vaccine Makers

“We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable ...

 January 25, 2022 | News

NMN Supplement: A Promising Anti-Aging Product or Still An Encouraging Lab Experiment With Ongoing Clinical Trials?

However, the effect of time on the human biology is such that no matter how cautious we remain on the fronts of physical activity as well as diet, age alwa...

 January 23, 2022 | News | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform

Waters extends its waters_connect informatics platform to support tandem quad mass spectrometers with new quantitation software application. MS Quan app...

 January 17, 2022 | News

Gaumard Scientific to Unveil the World's Most Advanced Multidisciplinary Patient Simulator, HAL® S530

Gaumard Scientific Co., an industry leader of simulation technology for healthcare education and training, today announced that  HAL® S5301, the w...

 January 17, 2022 | News

Illumina collaborates with Nashville Biosciences to accelerate medicines development

 Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

 January 11, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

 Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

 January 05, 2022 | News

5 Ways to Help Reduce the Risk of Birth Defects

Each year, birth defects affect about 1 in 33 babies born in the United States, according to the U.S. Centers for Disease Control and Prev...

 January 04, 2022 | News

World's first automated 24/7 blood pressure monitor comes to the USA

Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is bringing its 24/7 Blood Pressure Monitor to&nb...

 January 04, 2022 | News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

 January 03, 2022 | News

WHO SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Li...

 December 22, 2021 | News

WHO Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization ...

 December 10, 2021 | News

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executiv...

 December 09, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close